Sheng Yan

10PUBLICATIONS
20CO-AUTHORS
Molecular targetsSolid tumoursHaematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 30, 2026
Inhibiting PPM1D Perturbs Mitochondrial Integrity to Stimulate cGAS-STING Signaling and Antitumor Immunity.

|May 20, 2026
The STK33/mTORC1/S6K1/HIF-1α signalling axis drives glycolysis and progression in pancreatic neuroendocrine tumours.

|Feb 27, 2026
The Molecular Network of Neutrophil Extracellular Traps in Hepatocellular Carcinoma: Biogenesis, Function, and Therapeutic Implications.

Chang Liu, Jienan Lu, Yang Tian

|Nov 24, 2025
IGF2BP3 regulates EMP1 stability in an m6A-dependent manner and activates the TGF-β pathway to promote pancreatic cancer invasion.

Long Liu, Yu Zhang, Yuxi Huang

|Jul 29, 2023
Development and Validation of a Nomogram for Preoperative Prediction of Early Recurrence after Upfront Surgery in Pancreatic Ductal Adenocarcinoma by Integrating Deep Learning and Radiological Variables.

Fei Xiang, Xiang He, Xingyu Liu

|Nov 07, 2022
FAM83A promotes the progression and metastasis of human pancreatic neuroendocrine tumors by inducing the epithelial-mesenchymal transition via the PI3K/AKT and ERK pathways.

B Zhou, X Zhou, C Zhan

Pageof 2

Frequent Collaborators

2 joint publications

Sitong Zhang

2 joint publications

Zhenzhen Gao

1 joint publications

Yanjie Li

1 joint publications

Xin Han